NUBAD, LLC was founded in 2009 to commercialize DNA and RNA targeted technologies and drugs. NUBAD, LLC opened its labs in 2011 at Greenville Hospital System ITOR Facility (GHS-ITOR) located in Greenville, South Carolina, in a private sector innovation relationship platform.
NUBAD’s goal is to be a leading facilitator in the targeting of nucleic acid based drugs. The Company develops novel probes, assays, libraries and small molecule therapeutics targeting RNA and DNA structures identified as targets in human disease. As new genomic targets are identified, NUBAD’s technologies will assist discovery of RNA and DNA targeted small molecule drugs.
NUBAD, LLC is actively looking for academic and private partners to expand our technology. Please contact us for information regarding collaborative opportunities as well as questions regarding our science.